Navigation Links
Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips
Date:4/14/2011

NEW YORK, April 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Diagnostics Market: DNA Probes And Biochips

http://www.reportlinker.com/p0481335/Molecular-Diagnostics-Market DNA-Probes-And-Biochips.html

New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

FRANCE     GERMANY      ITALY      JAPAN      SPAIN      UK      USA

Introduction and Rationle

According to the 7-country study from Venture Planning Group, the global molecular diagnostics market is growing at the rate of 18% a year, and is expected to reach $10 billion in 5 years. The most rapid growth is projected for genetic and cancer tests.

The report was prepared by VPG in order to assist diagnostics industry executives in evaluating emerging opportunities and developing effective business, R&D and marketing strategies for this dynamic and rapidly evolving market segment.

Report Content

This two-volume, 1050-page report contains 96 tables and presents the following information:

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing, by country and market segment.

- Ten-year test volume and sales projections, by country.

Market Segmentation Analysis

- Sales and market shares for Roche, Gen-Probe and other major suppliers of molecular diagnostic tests and kit components, by country.

- Ten-year test volume and sales forecasts for major DNA probes and NAT applications, including:

• Infectious Diseases

• Forensic Testing

• Cancer

• Paternity Testing/HLA Typing

• Genetic Diseases

• Others

- Ten-year test volume and sales projections for 30  molecular diagnostic assays.

- A comprehensive analysis of the DNA sequencing market, by country and laboratory segment, including:

• Industrial

• Academic

• Government

• Commercial

- A detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.

Product/Technology Review

- A comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and others.

- An extensive review of the molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:

• PCR

• bDNA

• SDA

• NASBA

• TMA

• LCR

• SSSR, and others

- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive (up to 7 pages each) strategic assessments of 45 major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new projects in R&D.

- Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- 63 specific new product development opportunities with potentially significant market appeal during the next ten years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

The study is based on discussions with clinical pathologists, laboratory directors, as well as executives from leading companies and start-up firms developing innovative tests and instrumentation in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the technical and business publications, manufacturer product literature, industry analyst reports, as well as Venture Planning Group's proprietary data files was conducted.

To order this report:

: Molecular Diagnostics Market: DNA Probes And Biochips

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):